Coenzyme Q10 is one of 197 small molecule programs targeting Aphthous Ulcer. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
72 competitors in Polycystic Ovary Syndrome
Glucophage
Femara
Daliresp
Myrbetriq
Onglyza
Calciferol
Gynorest
Tradjenta
Topamax
Januvia
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details